Register
Login
Wednesday, February 22, 2012
Home
About Isotechnika
Our Team
Management
Robert Foster
Launa Aspeslet
Dennis Bourgeault
Derrick Freitag
Robert Huizinga
Board of Directors
Robert Foster
Wooyoung Choi
Prakash Gowd
Daniel Park
Peter Wijngaard
Donald Wyatt
Heung-Joon Yang
Products In Development
Voclosporin
What is Voclosporin?
Immunosuppression Market
Organ Transplantation
Why Immunosuppression?
Clinical Experience
Patents
Publications
NICAMs
About Drug Development
For Investors
News Releases
Financial Reports
Presentations
Investor & Stock Information
Corporate Governance
Media Coverage
FAQs
Partnership
Lux Biosciences
Paladin
3SBio
Vifor
Contact
News Releases
Financial Reports
Presentations
Investor & Stock Information
Corporate Governance
Media Coverage
FAQs
For Investors
News Releases
Home
About Isotechnika
Our Team
Management
Robert Foster
Launa Aspeslet
Dennis Bourgeault
Derrick Freitag
Robert Huizinga
Board of Directors
Robert Foster
Wooyoung Choi
Prakash Gowd
Daniel Park
Peter Wijngaard
Donald Wyatt
Heung-Joon Yang
Products In Development
Voclosporin
What is Voclosporin?
Immunosuppression Market
Organ Transplantation
Why Immunosuppression?
Clinical Experience
Patents
Publications
NICAMs
About Drug Development
For Investors
News Releases
Financial Reports
Presentations
Investor & Stock Information
Corporate Governance
Media Coverage
FAQs
Partnership
Lux Biosciences
Paladin
3SBio
Vifor
Contact
For Investors
News Releases
Financial Reports
Presentations
Investor & Stock Information
Corporate Governance
Media Coverage
FAQs
2012 News Releases
31 Jan 2012 - Isotechnika Terminates Existing Agreement wth ILJIN
06 Jan 2012-Isotechnika Announces Changes to Senior Management and Board of Directors
03 Jan 2012-Isotechnika Enters into Development and Commercialization License Agreement with Vifor
2011 News Releases
19 Dec 2011-Isotechnika Pharma Inc. Appoints Donald W. Wyatt to the Board or Directors
10 Nov 2011-Isotechnika Reports Third Quarter 2011 Financial Results
01 Nov 2011-Isotechnika Pharma Releases Shareholder Letter
20 Oct 2011-Isotechnika's Parnter, Lux Biosciences, Provides Uveitis Trial Recruitment Update
18 Oct 2011-Isotechnika Receives Positive Scientific Advice From The European Medicines Agency
11 Oct 2011-Isotechnika Pharma To Be Featured On 21st Century Health Television Series
05 Oct 2011-Voclosporin Study Published in the American Journal of Transplantation
23 Aug 2011-Isotechnika Pharma Inc. Appoints Robert B. Huizinga as Vice President, Clinical Affairs
10 Aug 2011-Isotechnika Pharma Inc. Appoints Daniel Park as Chief Business Officer
29 Jul 2011-Isotechnika Reports Second Quarter 2011 Financial Results
24 Jun 2011-Lux Biosciences to Appeal EMA Decision on Luveniq™
08 Jun 2011-Isotechnika Reports First Quarter 2011 Financial Results
25 Mar 2011-Isotechnika Reports Full Year and Fourth Quarter 2010 Financial Results
24 Feb 2011-Isotechnika Pharma's Partner, Lux Biosciences, Starts Enrollment in Phase 3 Uveitis...
18 Feb 2011-Isotechnika Welcomes New Board Members
02 Feb 2011-Isotechnika Receives Funding to Start Phase III Trial
2010 News Releases
Link
20 Dec 2010-Isotechnika and Paladin Submit Voclera(TM) (Voclosporin) For Canadian Approval for...
16 Dec 2010-Isotechnika Announces Shareholder Approval of Iljin Investment and New Board...
17 Nov 2010-Isotechnika Pharma Announces Conversion of Convertible Debenture
16 Nov 2010-Isotechnika Reports Development, Distribution and Licensing Agreement and Private...
09 Nov 2010-Isotechnika Reports Third Quarter 2010 Financial Results
01 Oct 2010-Isotechnika Pharma Announces Results of CONFIRM1 Trial with Drug Eluting Stent
07 Sep 2010-Isotechnika Pharma Announces Partial Conversion of Convertible Debenture
24 Aug 2010-Isotechnika Pharma and 3SBio Announce Strategic Partnership to Develop and...
11 Aug 2010-Isotechnika Reports Second Quarter 2010 Financial Results
04 Aug 2010-Lux Biosciences Receives Complete Response Letter From FDA For Voclosporin
23 Jun 2010-FDA Further Clarifies Lux Biosciences' Advisory Committee Meeting Cancellation
23 Jun 2010-FDA Cancels Advisory Committee Meeting for Voclosporin - Priority Review of Lux...
12 May 2010-Isotechnika Reports First Quarter 2010 Financial Results
11 May 2010-Isotechnika Partner Announces Advisory Committee Date For Voclosproin
30 Mar 2010-New Drug Application for Voclosporin Accepted for Priority Review by FDA
24 Mar 2010-Isotechnika Reports Full Year and Fourth Quarter 2009 Financial Results
04 Mar 2010-Isotechnika Pharma Receives National Research Council IRAP funding for NICAM Program
02 Mar 2010-European Authorities Accept Voclosporin for Regulatory Review
18 Feb 2010-Isotechnika Pharma Announces Sale of Isodiagnostika to Paladin Labs
04 Feb 2010-Isotechnika Partner Files for Approval of Voclosporin in US and Europe
Go
2009 News Releases
Link
11 Nov 2009-Isotechnika Pharma Reports Third Quaryter 2009 Financial Results
29 Oct 2009-Isotechnika Pharma Develops Portfolio of Non Immunosuppressive Cyclosporine Analogue...
27 Oct 2009-Isotechnika Pharma Announces Voclosporin Presentations at American Academy of...
13 Aug 2009-Isotechnika Pharma Appoints Dr. Jurgen Engel to Board of Directors
06 Aug 2009-Isotechnika Pharma Reports Second Quarter 2009 Financial Results
06 Jul 2009-Isotechnika Pharma Presents at the Canadian Dermatology Association Conference
25 Jun 2009-Isotechnika Announces New Chairman of the Board and Addition of New Board of Director...
18 Jun 2009-Isotechnika Pharma Announces the Closing of its Partnership with Paladin Labs
14 May 2009-Isotechnika Reports First Quarter 2009 Financial Results
07 May 2009-Isotechnika Announces a Strategic Collaboration and Financing with Paladin Labs
28 Apr 2009-Isotechnika Announces Phase 3 ESSENCE Data Meets Primary Endpoint in Psoriasis
21 Apr 2009-Isotechnika Announces Positive 12 Month Data from PROMISE Trial
27 Mar 2009-Isotechnika Reports Full Year and Fourth Quarter 2008 Financial Results
26 Mar 2009-Positive Phase 3 Uveitis Trial Results for Voclosporin Reported by Isotechnika's...
06 Mar 2009-Isotechnika Announces Partial Debt Repayment
05 Mar 2009-Isotechnika Selected to Present at the Annual Canadian Society of Transplantation...
17 Feb 2009-Isotechnika's Partner Initiates First-in-Man Study of LX214 (Voclosporin Ophthalmic...
28 Jan 2009-Isotechnika Provides Corporate Update
22 Jan 2009-Isotechnika Announces Full Enrollment Achieved in Partner Atrium's CONFIRM1 Trial...
Go
2008 News Releases
Link
26 Nov 2008-Isotechnika's Partner Receives European Medicines Agency Acceptance of its Pediatric...
14 Nov 2008-Isotechnika Reports Third Quarter Financial Results
03 Nov 2008-Isotechnika Selected to Present at the American Society of Nephrology Conference
16 Oct 2008-Isotechnika Partner Invited to Present on Drug Eluting Stent Trial Using Voclosporin
06 Oct 2008-Isotechnika Announces First Sale of Commercial Supply of Voclosporin
24 Sep 2008-Isotechnika Selected to Present at International Transplantation Conference
27 Aug 2008-Isotechnika Hires Advisors to Advance Strategic Alternatives
11 Aug 2008-Isotechnika Selected to Present at 22nd International Congress of the Transplantation...
06 Aug 2008-Isotechnika Reports Second Quarter Financial Results
31 Jul 2008-Preclinical Data for a Topical Formulation of Voclosporin as a Potential Best-in...
21 Jul 2008-Isotechnika Retains Global Rights to Voclosporin
25 Jun 2008-Full Enrollment Acheived in LUMINATE Pivotal Trial Program for Novel Uveitis Therapy...
18 Jun 2008-Isotechnika Obtains US$13 Million Debt Financing
17 Jun 2008-Isotechnika Announces Web Cast Details for Annual General and Special Meeting
17 Jun 2008-Isotechnika-Annual General and Special Meeting Webcast-June 19, 2008
11 Jun 2008-Voclosporin Coated Coronary Stent Implanted in First Patient
04 Jun 2008-Isotechnika Presents Positive Data from the PROMISE Trial of Voclosporin at the ATC
03 Jun 2008-Isotechnika to Hold Conference Call to Discuss Positive PROMISE Trial
29 May 2008-Drug-Eluting Coronary Stents Utilizing Isotechnika's Lead Drug Receive Approval to...
28 May 2008-Isotechnika Selected for Oral Presentation at the American Transplant Congress
27 May 2008-Isotechnika Reports Final Results of the PROMISE Trial
06 May 2008-Isotechnika Reports First Quarter Financial Results
28 Apr 2008-Isotechnika's Strategic Partner to Highlight Both Topical and Polymer Delivery...
24 Apr 2008-Isotechnika to be Represented at ARVO Conference with Multiple Presentations
17 Apr 2008-Isotechnika's Canadian Phase 3 Psoriasis Trial Published in The Lancet
03 Apr 2008-Isotechnika Will be Represented at American Society for Clinical Pharmacology and...
01 Apr 2008-Voclosporin Method Development Presented at Analytica
31 Mar 2008-Isotechnika's Independent Data Monitoring Committee Conducts Review of Phase 3...
27 Mar 2008-Isotechnika: ISA247 Issued Generic Name, Voclosporin
18 Mar 2008-Isotechnika Reports Full Year and Fourth Quarter 2007 Financial Results
07 Feb 2008-Isotechnika Appoints Colin Mallet to its Board of Directors
16 Jan 2008-Isotechnika to Provide Strategic Update
03 Jan 2008-Last Patient in Isotechnika's Phase 2b Kidney Transplant Trial Completes Six Month...
Go
2007 News Releases
Link
05 Dec 2007-Isotechnika Inc. Granted Patent for mTOR Inhibitor
26 Nov 2007-Isotechnika Inc. Strengthens Patent Position for ISA247
22 Nov 2007-Isotechnika Inc. Completes Critical Study
06 Nov 2007-Isotechnika Reports Third Quarter Results
10 Oct 2007-Isotechnika Inc. Appoints Two New Senior Company Officers
27 Sep 2007-Isotechnika Selected for Two Psoriasis Presentations at the World Dermatology Conference
25 Sep 2007-Isotechnika Inc. Announces Senior Management Changes
07 Sep 2007-Isotechnika Selected for Three Transplant Presentations at the International...
04 Sep 2007-Isotechnika Will be Represented at the Basic Science Symposium of the Transplantation...
22 Aug 2007-Isotechnika's Independent Data Monitoring Committee Conducts Second Review of Phase...
14 Aug 2007-Isotechnika Reports Second Quarter Results
07 Aug 2007-Isotechnika Invited to Present at Canaccord Adams Global Growth Conference
07 Aug 2007-Isotechnika's Lead Drug, ISA247, Receives Fast Track Designation from FDA for the...
02 Aug 2007-FDA Allows Long Term Use of ISA247 in Isotechnika Phase 2b Kidney Transplant Trial
01 Aug 2007-EMEA Committee Recommends Orphan Medicinal Product Designation for ISA247 for the...
23 Jul 2007-Isotechnika Completes Patient Recruitment of Pivotal Phase 3 Psoriasis Trial
28 Jun 2007-Isotechnika Will be Represented at the Canadian Dermatology Annual Conference
27 Jun 2007-Isotechnika Achieves Full Enrolment for ISA247 Phase 2b Kidney Transplant Trial
07 Jun 2007-Health Canada Allows Isotechnika to Continue Patients on ISA247 Until Commercialization
06 Jun 2007-Isotechnika Receives Approval from Polish Competent Authority for Pivotal Phase 3...
18 May 2007-Isotechnika Selected for Oral Presentation at the European Academy of Dermatology and...
09 May 2007-Isotechnika Reports First Quarter Results
09 May 2007-Isotechnika Inc. - Annual General Meeting Webcast-May 11, 2007
08 May 2007-Isotechnika Announces Web Cast Details for Annual General Meeting
07 May 2007-Isotechnika Announces Interim Three Month Data From Phase 2b Kidney Transplant Trial
06 May 2007-Advisory - Isotechnika to Announce Interim Three Month Data from Phase 2b Kidney...
04 May 2007-Isotechnika's Lead Drug, ISA247, to be Highlighted at the Association for Research in...
03 May 2007-Isotechnika Selected for Oral Presentation at the American Transplant Congress
02 May 2007-Isotechnika's Partner, Lux Biosciences, Receives No Objection Letter from Health...
23 Apr 2007-Isotechnika to Update Investment Community at Biofinance Business Forum
11 Apr 2007-Isotechnika to Host Educational Symposium at the American Transplant Congress
27 Mar 2007-Isotechnika's Independent Data Monitoring Committee Conducts Review of Phase 2b...
12 Mar 2007-Isotechnika Receives USAN Approval for Generic Name for Lead Immunosuppressive Drug
20 Feb 2007-Isotechnika's Partner, Lux Biosciences, Initiates LUMINATE Pivotal Trials in Uveitis...
15 Feb 2007-Isotechika Completes Bought Deal Financing for Total Proceeds of $40,422,500
Go
Archived News Releases
For archived press releases, please contact Investor Relations at
investorrelations@isotechnika.com
.